Coleus forskohlii

Alternative Medicine Review

Volumn 11, Issue 1, 2006, Pages 47-51

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; COLEUS FORSKOHLII EXTRACT; CYCLIC AMP; FENOTEROL; FORSKOLIN; LOCAL ANESTHETIC AGENT; OXYBUPROCAINE; PLANT EXTRACT; PROXYMETACAINE; UNCLASSIFIED DRUG;

ANGINA PECTORIS; ASTHMA; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COLEUS; COLEUS FORSKOHLII; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG USE; ECZEMA; ENZYME ACTIVATION; ENZYME ACTIVITY; FINGER TREMOR; GLAUCOMA; HUMAN; HYPERTENSION; METASTASIS; OBESITY; PLANT ROOT; PSORIASIS; REVIEW; WEIGHT REDUCTION;

EID: 33645769953     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Coleus forskohlii: Origin and botanical traits, www. tnsmpb.tn.gov.in/ images [Accessed January 13, 2006]
2. Ammon HP, Kemper FH. Ayurveda: 3000 years of Indian traditional medicine. Med Welt 1982;33:148-153. [Article in German]
3. Saksena AK, Green MJ, Shue HJ, et al. Identity of coleonol with forskolin: structure revision of a base-catalysed rearrangement product. Tetrahedron Lett 1985;26:551-554.
4. Ammon HP, Muller AB. Forskolin: from an Ayurvedic remedy to a modern agent. Planta Med 1985;6:473-477.
5. Forskohl's Coleus - Coleus forskohlii BRIQ (Lamiaceae) Phytochemicals. http://www. chromadex.com/Phytosearch/Forskolin.htm [Accessed January 13, 2006]
6. Metzger H, Lindner E. The positive inotropic-acting forskolin, a potent adenylate cyclase activator. Arzneimittelforschung 1981;31:1248-1250.
7. Seamon KB, Padgett W, Daly JW. Forskolin: unique diterpene activator of adenylate cyclase in membranes and intact cells. Proc Natl Acad Sci U S A 1981;78:3363-3367.
8. Marone G, Columbo M, Triggiani M, et al. Forskolin inhibits the release of histamine from human basophils and mast cells. Agents Actions 1986;18:96-99.
9. Dubey MP, Srimal RC, Nityanand S, Dhawan BN. Pharmacological studies on coleonol, a hypotensive diterpene from Coleus forskohlii. J Ethnopharmacol 1981;3:1-13.
10. Caprioli J, Sears M, Bausher L, et al. Forskolin lowers intraocular pressure by reducing aqueous inflow. Invest Ophthalmol Vis Sci 1984;25:268-277.
11. Agarwal KC, Parks RE Jr. Synergistic inhibition of platelet aggregation by forskolin plus PGE1 or 2-fluoroadenosine: effects of 2',5'-dideoxyadenosine and 5'-methylthioadenosine. Biochem Pharmacol 1982;31:3713-3716.
12. Wong S, Mok W, Phaneuf S, et al. Forskolin inhibits platelet-activating factor binding to platelet receptors independently of adenylyl cyclase activation. Eur J Pharmacol 1993;245:55-61.
13. Wysham DG, Brotherton AF, Heistad DD. Effects of forskolin on cerebral blood flow: implications for a role of adenylate cyclase. Stroke 1986;17:1299-1303.
14. Lichey I, Friedrich T, Priesnitz M, et al. Effect of forskolin on methacholine-induced bronchoconstriction in extrinsic asthmatics. Lancet 1984;2:167.
15. Haye B, Aublin JL, Champion S, et al. Chronic and acute effects of forskolin on isolated thyroid cell metabolism. Mol Cell Endocrinol 1985;43:41-50.
16. Roger PP, Servais P, Dumont JE. Regulation of dog thyroid epithelial cell cycle by forskolin, and adenylate cyclase activator. Exp Cell Res 1987;172:282-292.
17. Okuda H, Morimoto C, Tsujita T. Relationship between cyclic AMP production and lipolysis induced by forskolin in rat fat cells. J Lipid Res 1992;33:225-231.
18. Lindner E, Dohadwalla AN, Bhattacharya BK. Positive inotropic and blood pressure lowering activity of a diterpene derivative isolated from Coleus forskohlii: forskolin. Arzneimittelforschung 1978;28:284-289.
19. Mills I, Moreno FJ, Fain JN. Forskolin inhibition of glucose metabolism in rat adipocytes independent of adenosine 3',5'-monophosphate accumulation and lipolysis. Endocrinology 1984;115:1066-1069.
20. Kramer W, Thormann J, Kindler M, Schlepper M. Effects of forskolin on left ventricular function in dilated cardiomyopathy. Arzneimittelforschung 1987;37:364-367.
21. Schlepper M, Thormann J, Mitrovic V. Cardiovascular effects of forskolin and phosphodiesterase-III inhibitors. Basic Res Cardiol 1989;84:S197-S212.
22. Siegl AM, Daly JW, Smith JB. Inhibition of aggregation and stimulation of cyclic AMP generation in intact human platelets by the diterpene forskolin. Mol Pharmacol 1982;21:680-687.
23. Bauer K, Dietersdorfer F, Serti K, et al. Pharmacodynamic effects of inhaled dry powder formulations of fenoterol and colforsin in asthma. Clin Pharmacol Ther 1993;53:76-83.
24. Caprioli J, Sears M. Forskolin lowers intraocular pressure in rabbits, monkeys, and man. Lancet 1983;1:958-960.
25. Seto C, Eguchi S, Araie M, et al. Acute effects of topical forskolin on aqueous humor dynamics in man. Jpn J Ophthalmol 1986;30:238-244.
26. Meyer BH, Stulting AA, Muller FO, et al. The effects of forskolin eye drops on intra-ocular pressure. S Afr Med J 1987;71:570-571.
27. Kim HK, Song KS, Chung JH, et al. Platelet microparticles induce angiogenesis in vitro. Br J Haematol 2004;124:376-384.
28. Agarwal KC, Parks RE Jr. Forskolin: a potential antimetastatic agent. Int J Cancer 1983;32:801-804.
29. Allen DO, Ahmed B, Naseer K. Relationships between cyclic AMP levels and lipolysis in fat cells after isoproterenol and forskolin stimulation. J Pharmacol Exp Ther 1986;238:659-664.
30. Han LK, Morimoto C, Yu RH, Okuda H. Effects of Coleus forskohlii on fat storage in ovariectomized rats. Yakugaku Zasshi 2005;125:449-453.
31. Martin LF, Klim CM, Vannucci SJ, et al. Alterations in adipocyte adenylate cyclase activity in morbidly obese and formerly morbidly obese humans. Surgery 1990;108:228-234.
32. Badmaev V, Majeed M, Conte A, Parker JE. Diterpene forskolin: a possible new compound for reduction of body weight by increasing lean body mass. Townsend Lett 2001;June:115.
33. Wachtel H, Loschmann PA. Effects of forskolin and cyclic nucleotides in animal models predictive of antidepressant activity: interactions with rolipram. Psychopharmacology (Bed) 1986;90:430-435.
34. Schorlemmer HU. Forskolin for immune stimulation. Chem Abstr 1985;102:1009.
35. Krall JF, Fernandez EI, Connelly-Fittingoff M. Human aging: effect on the activation of lymphocyte cyclic AMP-dependent protein kinase by forskolin. Proc Soc Exp Biol Med 1987;184:396-402.